Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.
about
Lipid-lowering efficacy of rosuvastatinLipid lowering efficacy of rosuvastatinTriglyceride-rich lipoproteins as a causal factor for cardiovascular diseaseSoy-based renoprotectionClinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reductionDyslipidemia management in primary prevention of cardiovascular disease: Current guidelines and strategiesOrigin and therapy for hypertriglyceridaemia in type 2 diabetesApplying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the futureOmega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemiaPCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the futureNonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB CouncilPCSK9 Inhibition With Monoclonal Antibodies: Modern Management of HypercholesterolemiaLipid-related markers and cardiovascular disease prediction.A Comparative Overview of Prescription Omega-3 Fatty Acid ProductsEfficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.Association of the ST3GAL4 rs11220462 polymorphism and serum lipid levels in the Mulao and Han populationsEffects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials.Intercorrelations of lipoprotein subfractions and their covariation with lifestyle factors in healthy men.Statin-ezetimibe versus statin lipid-lowering therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventionBlood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.Discordant Lipid Pattern and Carotid Atherosclerotic Plaque. Importance of Remnant CholesterolInflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represRelations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trialsThe polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglyceridesClinical and preclinical pharmacokinetics and pharmacodynamics of mipomersen (kynamro(®)): a second-generation antisense oligonucleotide inhibitor of apolipoprotein BPlasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.Molecular imaging of low-density lipoprotein in human coronary plaques by color fluorescent angioscopy and microscopyHigh-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapyIndependent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis.Observational study of effects of Saroglitazar on glycaemic and lipid parameters on Indian patients with type 2 diabetesConsensus statement on management of dyslipidemia in Indian subjects.Erythrocyte-bound apolipoprotein B in relation to atherosclerosis, serum lipids and ABO blood group.Effect of a moderate fat diet with and without avocados on lipoprotein particle number, size and subclasses in overweight and obese adults: a randomized, controlled trialVery low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial.
P2860
Q24187891-4C01400D-9EF5-469F-BD18-4F41EDAEA378Q24202620-BEF279B0-A102-4B22-A4CD-3AD2AB175940Q26745946-9505A924-F0BD-4649-B10D-36838BD04381Q26751544-187E5D62-6D58-48CF-BA36-EB4890B661D7Q26752950-E399D017-7733-4D1D-A603-DF262AA771B1Q26765157-AFD79A0F-1149-4C00-9612-7177FB385FD5Q26824004-05F714D0-36E9-4D42-972C-B5198072D426Q28074451-71D374A7-674A-47B2-8E5F-759DB086E615Q28076399-A7E91EE4-B477-4BE1-A5E7-F533C633EC0DQ28083595-5AC6A962-85CD-4195-9A11-6495AA4A1BA6Q28084156-A19149EA-E9F1-431C-A611-4CCF697AAC01Q28275648-CA35F848-169B-4F23-A49F-5E956614947EQ28654304-6BB9D156-9ED1-4647-B070-D5A5CEBF845DQ28972330-55B78484-D7E1-4B83-A7E3-00BA5DAAD4CCQ30369889-1958CACB-8541-425B-99F9-4E40597B6FADQ30585937-66BD58F2-7A6F-4CB4-8CEA-00CA2DE07DFEQ30599909-C51A8828-C4A9-47D7-9349-EFF4C0D54500Q33604888-57A676C8-3BBF-48DA-82E0-70D9E1E7DE90Q33670893-B7551CDC-A212-4689-82B7-83751AEC227BQ33701744-DF643E8B-7C0F-4131-8FBE-7ECE7009BF96Q33780134-ED17DF04-81F9-4FB8-A5F9-29E7776BA281Q33789181-597B1A97-1141-4637-8A53-D92F2BBB86BCQ33848771-C315C43D-CF3D-4924-9E5C-EE8E716C5D23Q33891946-4373DC11-A048-415F-B86C-CE59EEAAB080Q33970677-F4C2B379-9576-4DD0-95DB-690E3E556E3AQ34046881-A807B1EE-7283-4265-9BFA-019FE6C73502Q34297213-E5F365DE-99A6-4435-B2B9-A789963444A1Q34359967-240A0CE7-EE9E-4654-B0F5-D0BA48593596Q34406987-22C808E3-52D3-4F26-AB63-E027992E6409Q34456562-28ECC3D9-0A55-49B6-9CF8-F064DC09B683Q34480492-BA263411-E02B-40D7-ACA2-D99D9B03C3F5Q34500613-73B8EEEC-B479-432C-844D-B00B6C88BA30Q34729515-C18B157F-61CE-45A1-937C-61EFB3DE7143Q34729697-936ABE68-944C-44EC-A823-BBBBE7A4CF76Q34877739-BE7B6C9B-3E57-4A80-BE3C-DA37D3077B6FQ34980772-45D35BF6-CF29-41F1-8F72-9D3D90B74C98Q34999677-A2348C3D-C168-40D5-A737-376FA95F4640Q35088101-DEE6B0B0-A077-4742-B016-9FB8C5936C8EQ35645239-B1198384-3480-4CA7-B4C8-8705D001638CQ35667598-69720E31-EBE2-4F00-917A-FB6E6541F436
P2860
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Association of LDL cholesterol ...... with statins: a meta-analysis.
@en
Association of LDL cholesterol ...... with statins: a meta-analysis.
@nl
type
label
Association of LDL cholesterol ...... with statins: a meta-analysis.
@en
Association of LDL cholesterol ...... with statins: a meta-analysis.
@nl
prefLabel
Association of LDL cholesterol ...... with statins: a meta-analysis.
@en
Association of LDL cholesterol ...... with statins: a meta-analysis.
@nl
P2093
P921
P356
P1476
Association of LDL cholesterol ...... with statins: a meta-analysis.
@en
P2093
Aeilko H Zwinderman
Andrew M Tonkin
Antonio M Gotto
Benoit J Arsenault
David A DeMicco
Graham A Hitman
John C LaRosa
John J P Kastelein
John R Downs
K M A Welch
P304
P356
10.1001/JAMA.2012.366
P407
P577
2012-03-01T00:00:00Z